Increased risk of cardiovascular events with coxibs and NSAIDs [1] (multiple letters)

Lancet

Volumn 365, Issue 9470, 2005, Pages 1537-1539

  Scott, David G I ^a   Watts, Richard A ^b   Dachman, Rebecca ^c   Emery, Paul ^d   Moore, Andrew ^e   Hawkey, Chris ^f   Thomas, L G ^c  

^a NORFOLK AND NORWICH UNIVERSITY HOSPITAL   (United Kingdom)

^b IPSWICH HOSPITAL   (United Kingdom)

^c University of Oxford ^*  (United Kingdom)

^d UNIVERSITY OF LEEDS   (United Kingdom)

^e UNIVERSITY OF OXFORD   (United Kingdom)

^f NOTTINGHAM UNIVERSITY HOSPITALS NHS TRUST   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CELECOXIB; CONTRACEPTIVE AGENT; CYCLOOXYGENASE 2 INHIBITOR; NAPROXEN; NONSTEROID ANTIINFLAMMATORY AGENT; ROFECOXIB; PROSTAGLANDIN SYNTHASE INHIBITOR; LACTONE; SULFONE;

ARTHRITIS; CARDIOTOXICITY; CLINICAL TRIAL; DRUG SURVEILLANCE PROGRAM; GASTROINTESTINAL TOXICITY; HEART INFARCTION; HUMAN; LETTER; MEDICAL ETHICS; MEDICAL SOCIETY; MORTALITY; OSTEOARTHRITIS; POISSON DISTRIBUTION; PRACTICE GUIDELINE; PRESCRIPTION; PRIORITY JOURNAL; PROSTATE CANCER; RHEUMATOID ARTHRITIS; SMOKING HABIT; STATISTICAL ANALYSIS; STROKE; THROMBOSIS; ULCERATIVE COLITIS; CARDIOVASCULAR DISEASE; CHEMICALLY INDUCED DISORDER; DRUG CONTROL; METHODOLOGY; NOTE; RISK FACTOR;

ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; CARDIOVASCULAR DISEASES; CYCLOOXYGENASE INHIBITORS; DRUG AND NARCOTIC CONTROL; HUMANS; RISK FACTORS; LACTONES; OSTEOARTHRITIS; SULFONES;

MLCS; MLOWN;

EID: 20544453491     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(05)66445-8     Document Type: Letter

References (0)